392 related articles for article (PubMed ID: 26330257)
1. Trends in Modern Drug Discovery.
Eder J; Herrling PL
Handb Exp Pharmacol; 2016; 232():3-22. PubMed ID: 26330257
[TBL] [Abstract][Full Text] [Related]
2. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
3. [Biomarkers: "Found in translation"].
Lockhart BP; Walther B
Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
[TBL] [Abstract][Full Text] [Related]
4. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Open-access public-private partnerships to enable drug discovery--new approaches.
Müller S; Weigelt J
IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
[TBL] [Abstract][Full Text] [Related]
7. Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches.
Lee JA; Berg EL
J Biomol Screen; 2013 Dec; 18(10):1143-55. PubMed ID: 24080259
[TBL] [Abstract][Full Text] [Related]
8. New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent.
Hausheer FH; Kochat H; Parker AR; Ding D; Yao S; Hamilton SE; Petluru PN; Leverett BD; Bain SH; Saxe JD
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S3-15. PubMed ID: 12819940
[TBL] [Abstract][Full Text] [Related]
9. Opportunities and challenges in the discovery of new central nervous system drugs.
Krause JE; Chenard BL
Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381
[TBL] [Abstract][Full Text] [Related]
10. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
Hafner J
J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
[TBL] [Abstract][Full Text] [Related]
11. Academic-industrial partnerships in drug discovery in the age of genomics.
Harris T; Papadopoulos S; Goldstein DB
Trends Biotechnol; 2015 Jun; 33(6):320-2. PubMed ID: 25987446
[TBL] [Abstract][Full Text] [Related]
12. [Impacts of modern biology on drug discovery].
Guo JB; Li XJ
Sheng Li Ke Xue Jin Zhan; 2007 Jan; 38(1):25-31. PubMed ID: 17438949
[TBL] [Abstract][Full Text] [Related]
13. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
14. Why and how have drug discovery strategies in pharma changed? What are the new mindsets?
Mignani S; Huber S; Tomás H; Rodrigues J; Majoral JP
Drug Discov Today; 2016 Feb; 21(2):239-49. PubMed ID: 26376356
[TBL] [Abstract][Full Text] [Related]
15. The application of Chinese medicine to novel drug discovery.
Sucher NJ
Expert Opin Drug Discov; 2013 Jan; 8(1):21-34. PubMed ID: 23170842
[TBL] [Abstract][Full Text] [Related]
16. Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning.
Janero DR
Expert Opin Drug Discov; 2014 Nov; 9(11):1265-79. PubMed ID: 25162124
[TBL] [Abstract][Full Text] [Related]
17. How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of Practice.
Haasen D; Schopfer U; Antczak C; Guy C; Fuchs F; Selzer P
Assay Drug Dev Technol; 2017; 15(6):239-246. PubMed ID: 28800248
[TBL] [Abstract][Full Text] [Related]
18. Orphan diseases: state of the drug discovery art.
Volmar CH; Wahlestedt C; Brothers SP
Wien Med Wochenschr; 2017 Jun; 167(9-10):197-204. PubMed ID: 26819216
[TBL] [Abstract][Full Text] [Related]
19. Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation.
Ackermann BL; Berna MJ; Eckstein JA; Ott LW; Chaudhary AK
Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():357-96. PubMed ID: 20636083
[TBL] [Abstract][Full Text] [Related]
20. The inadequacy of the reductionist approach in discovering new therapeutic agents against complex diseases.
Duval MX
Exp Biol Med (Maywood); 2018 Aug; 243(12):1004-1013. PubMed ID: 30089398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
